Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy
about
Pseudomonas aeruginosa biofilms in cystic fibrosisA Lipid Mediator Hepoxilin A3 Is a Natural Inducer of Neutrophil Extracellular Traps in Human NeutrophilsWhy is Pseudomonas aeruginosa a pathogen?Polyelectrolyte properties of filamentous biopolymers and their consequences in biological fluids.Antimicrobial Efficacy of Contact Lens Care Solutions Against Neutrophil-Enhanced Bacterial Biofilms.Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTR.Pseudomonas aeruginosa infectious keratitis in a high oxygen transmissible rigid contact lens rabbit modelNeutrophil extracellular traps and bacterial biofilms in middle ear effusion of children with recurrent acute otitis media--a potential treatment targetEnhanced in vitro formation and antibiotic resistance of nonattached Pseudomonas aeruginosa aggregates through incorporation of neutrophil products.Mycobacterium abscessus induces a limited pattern of neutrophil activation that promotes pathogen survival.Disruption of contact lens-associated Pseudomonas aeruginosa biofilms formed in the presence of neutrophils.Expression of antimicrobial drug tolerance by attached communities of Mycobacterium tuberculosis.Polyelectrolyte-mediated increase of biofilm mass formation.Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in staphylococciCandidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites.The exopolysaccharide Psl-eDNA interaction enables the formation of a biofilm skeleton in Pseudomonas aeruginosa.Innate Immune Signaling Activated by MDR Bacteria in the AirwayEffects of azithromycin in Pseudomonas aeruginosa burn wound infection.Biofilm matrix and its regulation in Pseudomonas aeruginosa.Mycobacterium avium biofilm attenuates mononuclear phagocyte function by triggering hyperstimulation and apoptosis during early infection.Insulin treatment modulates the host immune system to enhance Pseudomonas aeruginosa wound biofilms.Interactions between Neutrophils and Pseudomonas aeruginosa in Cystic Fibrosis.The immune system vs. Pseudomonas aeruginosa biofilms.Challenges and advances in the development of inhalable drug formulations for cystic fibrosis lung disease.The effects of silicone hydrogel lens wear on the corneal epithelium and risk for microbial keratitis.The granuloma in tuberculosis: dynamics of a host-pathogen collusion.Pseudomonas aeruginosa biofilm infections: from molecular biofilm biology to new treatment possibilities.Residence in biofilms allows Burkholderia cepacia complex (Bcc) bacteria to evade the antimicrobial activities of neutrophil-like dHL60 cells.Biofilms and host response - helpful or harmful.A Critical Role for Extracellular DNA in Dental Plaque Formation.Extracellular DNA and F-actin as targets in antibiofilm cystic fibrosis therapy.Exopolysaccharide biosynthetic glycoside hydrolases can be utilized to disrupt and prevent Pseudomonas aeruginosa biofilms.NET balancing: a problem in inflammatory lung diseases.The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis.Targeting polyelectrolyte networks in purulent body fluids to modulate bactericidal properties of some antibiotics.Acceleration of the formation of biofilms on contact lens surfaces in the presence of neutrophil-derived cellular debris is conserved across multiple genera.Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules.Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against Pseudomonas aeruginosa in Cystic Fibrosis. An Argumentative Review.Host Defence against Bacterial Biofilms: “Mission Impossible”?Characterization of eDNA from the clinical strain Acinetobacter baumannii AIIMS 7 and its role in biofilm formation
P2860
Q28299966-7F347209-8E5C-4B02-9EB9-AF70D58E2CF9Q29013771-7875A81C-17DD-4E96-87C2-AD1C466F6BDDQ30434529-5FD9F3D8-0100-4925-918D-F40A6920D514Q33563964-08289515-E681-48DC-833A-E3E17BA7650BQ33626325-9A9D1294-5F85-4D2D-947E-C9765A91888BQ34016539-65E150A7-FE92-4FA3-816E-CA3F6852958AQ34211398-98986430-07BA-4130-BC94-67D70CFC9D26Q34580853-C9654ACF-53AE-4FA2-8F34-726E13DE0B72Q34596738-8987EB9B-4C3B-48D6-861D-13D80210B08DQ34603485-66C94423-13D7-431E-B853-8881BB32FC90Q34937175-FB3B7E0D-DEF6-4153-8209-45157A89D9BEQ35180731-9BF7CD78-FD6A-402D-85B8-68BF0F636B58Q35654991-C9754F11-8808-4F4D-972F-16556CD1239FQ35782697-57C77D81-B310-4870-AD54-736EDF48E8C6Q36055572-711B75E5-3A3E-4F64-BF4C-CE6398627510Q36307388-E8D9D495-921F-4B33-AB0D-D2EB26B757BDQ36422470-0D587B4B-49CB-4336-ABF0-C8508BC84745Q37018035-57840200-B2A1-4F46-B162-CCF33203E3D3Q37291396-E0296249-CF7C-4F0E-901E-66F5A286E48DQ37548070-7701673B-5FC1-4EB6-A886-0510B4814D99Q37548115-5071F172-B6E3-4FEE-8C07-54C33849243DQ37727995-51238303-8CAF-4517-8719-BA9108F230A6Q37767747-8C06700A-D023-4552-B6F1-1493E05A9611Q37849777-ABF26A5C-AE51-44EA-850A-330B01E8B8E0Q38069767-B8640338-0EE2-4271-8706-B2402D0CAEF6Q38073249-F6B3CB0B-65D6-4024-B24E-58F53A786D02Q38268531-8A2D6A6E-A985-4149-84F2-7F3CC32C6831Q38835228-68F2A939-F5B0-4E0B-A20B-B41C665423A1Q39240791-A1DC17EB-7496-4206-AA3D-883002AB7E76Q39260148-01519724-941B-4B55-B7C5-C5D7AA3F9703Q39957550-74EFF72B-3B93-4D09-AD75-EB0D263C5E24Q40622669-E26C9336-3F00-47C6-9BA9-FC4E55C916EBQ42947423-B78E8396-3FD0-4054-A794-ADD50A0CED68Q47730320-4BE61166-C64C-4682-B15C-7C9607BAEB13Q49387443-8EB67E33-FF6E-4DCD-9D5A-8EF3F03AB6E3Q50106512-6375CEBC-6B21-4AE7-BA43-439230B42D46Q51736541-1873B9B4-2641-427F-9289-0E9BA039A36BQ54205022-39462660-BDBF-4DF1-9997-F970D8338331Q58692848-5920C379-3E06-4C40-BEF1-D2E1F73AAF0BQ58915158-B51D9D24-7DAF-4EF3-813A-E6C0157F0323
P2860
Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Neutrophil enhancement of Pseu ...... and DNA as targets for therapy
@ast
Neutrophil enhancement of Pseu ...... and DNA as targets for therapy
@en
Neutrophil enhancement of Pseu ...... and DNA as targets for therapy
@nl
type
label
Neutrophil enhancement of Pseu ...... and DNA as targets for therapy
@ast
Neutrophil enhancement of Pseu ...... and DNA as targets for therapy
@en
Neutrophil enhancement of Pseu ...... and DNA as targets for therapy
@nl
prefLabel
Neutrophil enhancement of Pseu ...... and DNA as targets for therapy
@ast
Neutrophil enhancement of Pseu ...... and DNA as targets for therapy
@en
Neutrophil enhancement of Pseu ...... and DNA as targets for therapy
@nl
P2093
P2860
P3181
P356
P1476
Neutrophil enhancement of Pseu ...... and DNA as targets for therapy
@en
P2093
Jerry A Nick
Katie R Poch
Kenneth C Malcolm
Michael L Vasil
Quinn M Parks
Robert L Young
P2860
P304
P3181
P356
10.1099/JMM.0.005728-0
P407
P577
2009-04-01T00:00:00Z